SCHEMBL24044482

SCHEMBL24044482

CC(=O)N1CCC[C@H](N)[C@@H]1CO[C@H]1CC[C@@H](c2ccccc2)CC1

nearest known ligand 0.70

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ HCRTR2 O43614 20/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24044741 0.94 HCRTR2 (0.71) HCRTR2
SCHEMBL24044740 0.94 HCRTR2 (0.71) HCRTR2
SCHEMBL24284026 0.91 HCRTR2 (0.71) HCRTR2
SCHEMBL24044699 0.91 HCRTR2 (0.71) HCRTR2
SCHEMBL24044384 0.91 HCRTR2 (0.70) HCRTR2
SCHEMBL24284243 0.89 HCRTR2 (0.72) HCRTR2
SCHEMBL19250051 0.89 HCRTR2 (0.72) HCRTR2
SCHEMBL24044629 0.89 HCRTR2 (0.71) HCRTR2
SCHEMBL24044420 0.88 HCRTR2 (0.70) HCRTR2
SCHEMBL24044338 0.88 HCRTR2 (0.69) HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3984994-B1 SUBSTITUTED PIPERIDINE COMPOUND AS OREXIN TYPE 2 AGONIST FOR THE TREATMENT OF NARCOLEPSY TAKEDA PHARMACEUTICALS CO (JP) 2024-07-03 — — EP disclosed
EP-3984994-A1 SUBSTITUTED PIPERIDINE COMPOUND AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2022-04-20 — — EP disclosed
EP-3411358-B1 SUBSTITUTED PIPERIDINE COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICALS CO (JP) 2021-11-24 — — EP disclosed
Send feedback